These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 27477870

  • 1. Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms.
    Chang ML, Liang KH, Ku CL, Lo CC, Cheng YT, Hsu CM, Yeh CT, Chiu CT.
    Sci Rep; 2016 Aug 01; 6():30799. PubMed ID: 27477870
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
    Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J, Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D, Mozer-Lisewska I, Januszkiewicz-Lewandowska D.
    World J Gastroenterol; 2017 Jun 07; 23(21):3815-3824. PubMed ID: 28638221
    [Abstract] [Full Text] [Related]

  • 3. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M, Leung R, Romero-Gomez M, Mangia A, Irving WL, Sheridan D, Spengler U, Mollison L, Cheng W, Bugianesi E, McLeod D, Zaitoun AM, Attino V, Goeltz D, Nattermann J, Douglas M, Booth DR, George J, Ahlenstiel G.
    J Hepatol; 2014 Aug 07; 61(2):235-41. PubMed ID: 24768758
    [Abstract] [Full Text] [Related]

  • 4. Relation of resistin gene variants to resistin plasma levels and altered susceptibility to polycystic ovary syndrome: A case control study.
    Al-Awadi AM, Saldhana FL, Bauyrzhanova Z, Nemr R, Mahmood NA, Almawi WY.
    Am J Reprod Immunol; 2023 Jul 07; 90(1):e13731. PubMed ID: 37382171
    [Abstract] [Full Text] [Related]

  • 5. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
    Chang KC, Tseng PL, Wu YY, Hung HC, Huang CM, Lu SN, Wang JH, Lee CM, Chen CH, Tsai MC, Yen YH, Lin MT, Wu CK, Huang CC, Chen HH, Hu TH.
    Clin Gastroenterol Hepatol; 2015 May 07; 13(5):1017-24. PubMed ID: 25460552
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms of the resistin gene and their association with obesity and resistin levels in Malaysian Malays.
    Apalasamy YD, Rampal S, Salim A, Moy FM, Su TT, Majid HA, Bulgiba A, Mohamed Z.
    Biochem Genet; 2015 Jun 07; 53(4-6):120-31. PubMed ID: 25991560
    [Abstract] [Full Text] [Related]

  • 7. Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites.
    Nakatochi M, Ichihara S, Yamamoto K, Ohnaka K, Kato Y, Yokota S, Hirashiki A, Naruse K, Asano H, Izawa H, Matsubara T, Yokota M.
    Diabetologia; 2015 Dec 07; 58(12):2781-90. PubMed ID: 26404063
    [Abstract] [Full Text] [Related]

  • 8. Variants in RETN gene are associated with steroid-induced osteonecrosis of the femoral head risk among Han Chinese people.
    An F, Zhang L, Gao H, Wang J, Liu C, Tian Y, Ma C, Zhao J, Wang K, Wang J.
    J Orthop Surg Res; 2020 Mar 06; 15(1):96. PubMed ID: 32143662
    [Abstract] [Full Text] [Related]

  • 9. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
    Akkarathamrongsin S, Thong VD, Payungporn S, Poovorawan K, Prapunwattana P, Poovorawan Y, Tangkijvanich P.
    J Med Virol; 2014 Sep 06; 86(9):1482-90. PubMed ID: 24782280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H, Abe H, Seki N, Sugita T, Aida Y, Itagaki M, Sutoh S, Shimada N, Furihata T, Tsubota A, Aizawa Y.
    World J Gastroenterol; 2015 Apr 07; 21(13):3904-11. PubMed ID: 25852275
    [Abstract] [Full Text] [Related]

  • 12. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S, Kim SR, Amano K, Iio E, Yoon S, Hirohata S, Yano Y, Ishikawa T, Katsushima S, Komeda T, Fukunaga T, Chung H, Kokuryu H, Horie Y, Hatae T, Fujinami A, Kim SK, Kudo M, Tanaka Y.
    Dig Dis; 2017 Apr 07; 35(6):531-540. PubMed ID: 29040985
    [Abstract] [Full Text] [Related]

  • 13. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
    Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, Goteti VS, Brass CA, Albrecht JK, Bacon BR, SPRINT-2 and RESPOND-2 Investigators.
    Gastroenterology; 2012 Sep 07; 143(3):608-618.e5. PubMed ID: 22626609
    [Abstract] [Full Text] [Related]

  • 14. Common quantitative trait locus downstream of RETN gene identified by genome-wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect.
    Chung CM, Lin TH, Chen JW, Leu HB, Yin WH, Ho HY, Sheu SH, Tsai WC, Chen JH, Lin SJ, Pan WH.
    Diabetes Metab Res Rev; 2014 Mar 07; 30(3):232-40. PubMed ID: 24123702
    [Abstract] [Full Text] [Related]

  • 15. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
    Haj-Sheykholeslami A, Keshvari M, Sharafi H, Pouryasin A, Hemmati K, Mohammadzadehparjikolaei F.
    World J Gastroenterol; 2015 Aug 07; 21(29):8935-42. PubMed ID: 26269684
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
    O'Connor KS, George J, Booth D, Ahlenstiel G.
    World J Gastroenterol; 2014 Dec 21; 20(47):17830-8. PubMed ID: 25548481
    [Abstract] [Full Text] [Related]

  • 17. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM, García-Samaniego J, García M, Madejón A, Martín-Carbonero L, Cabello A, Álvarez B, Górgolas M, Rallón N.
    J Interferon Cytokine Res; 2017 Jun 21; 37(6):278-286. PubMed ID: 28440692
    [Abstract] [Full Text] [Related]

  • 18. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.
    Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, Meigs JB, Florez JC.
    Diabetes; 2009 Mar 21; 58(3):750-6. PubMed ID: 19074981
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L, Di Biagio A, Sartini M, Rappazzo E, Nicolini LA, Cenderello G, Valle C, Azzola E, Grasso A, De Leo P, Boldrini A, Setti M, Prinapori R, Lorusso C, Bruzzone B, Icardi G, Ligurian HIV Network.
    New Microbiol; 2015 Oct 21; 38(4):499-509. PubMed ID: 26485009
    [Abstract] [Full Text] [Related]

  • 20. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
    Chen Y, Xu HX, Wang LJ, Liu XX, Mahato RI, Zhao YR.
    Aliment Pharmacol Ther; 2012 Jul 21; 36(2):91-103. PubMed ID: 22591106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.